Trial Profile
A Phase I Clinical Trial of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-Beta (BG00001, Ad.hIFN-beta) for Pleural Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2020
Price :
$35
*
At a glance
- Drugs Interferon-beta gene therapy (Primary) ; Nadofaragene-firadenovec
- Indications Mesothelioma
- Focus Adverse reactions
- 16 Mar 2020 Status changed from active, no longer recruiting to completed.
- 29 Sep 2010 Planned end date changed from 1 Mar 2008 to 1 Mar 2023 as reported by ClinicalTrials.gov.
- 29 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.